Personalized Dendritic Cell Vaccine Pilot for High Risk TNBC After Neoadjuvant Therapy

NCT06435351 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Triple Negative Breast Cancer

Interventions

PROCEDURE: Leukapheresis
BIOLOGICAL: Dendritic Cell (DC) Vaccine

Sponsor

H. Lee Moffitt Cancer Center and Research Institute